These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Rapidly fatal multiorgan Langerhans cell histiocytosis in a neonate. Gee SN; Huang JT; Schmidt BA; Gellis SE Pediatr Dermatol; 2013; 30(5):e85-6. PubMed ID: 23278554 [TBL] [Abstract][Full Text] [Related]
43. Successful treatment of adult multisystemic Langerhans cell histiocytosis with psoralen-UV-A, prednisolone, mercaptopurine, and vinblastine. von Stebut E; Schadmand-Fischer S; Bräuninger W; Kreft A; Doberauer C; Steinbrink K Arch Dermatol; 2008 May; 144(5):649-53. PubMed ID: 18490592 [TBL] [Abstract][Full Text] [Related]
44. Need for a cooperative study: Pulmonary Langerhans cell histiocytosis and its management in adults. McClain KL; Gonzalez JM; Jonkers R; De Juli E; Egeler M Med Pediatr Oncol; 2002 Jul; 39(1):35-9. PubMed ID: 12116077 [TBL] [Abstract][Full Text] [Related]
45. Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon? Christie LJ; Evans AT; Bray SE; Smith ME; Kernohan NM; Levison DA; Goodlad JR Hum Pathol; 2006 Jan; 37(1):32-9. PubMed ID: 16360413 [TBL] [Abstract][Full Text] [Related]
50. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients. Wang KH; Chen WY; Liu HN; Huang CC; Lee WR; Hu CH Br J Dermatol; 2006 Feb; 154(2):277-86. PubMed ID: 16433797 [TBL] [Abstract][Full Text] [Related]
51. Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. Geissmann F; Emile JF; Andry P; Thomas C; Fraitag S; De Prost Y; Brousse N J Pathol; 1997 Mar; 181(3):301-4. PubMed ID: 9155716 [TBL] [Abstract][Full Text] [Related]
52. A case report of langerhans histiocytosis presenting sequentially over a 21-year period with Letterer-Siwe disease, hand-Schuller-Christian disease and eosinophillic granuloma of bone. Iupati D; Chander S J Pediatr Hematol Oncol; 2006 Nov; 28(11):746-9. PubMed ID: 17114962 [TBL] [Abstract][Full Text] [Related]
53. Primary musculoskeletal Langerhans cell histiocytosis in children: an analysis for a 3-decade period. Arkader A; Glotzbecker M; Hosalkar HS; Dormans JP J Pediatr Orthop; 2009 Mar; 29(2):201-7. PubMed ID: 19352248 [TBL] [Abstract][Full Text] [Related]
54. Langerhans's cell histiocytosis in old subjects: two rare case reports and review of the literature. Lajolo C; Campisi G; Deli G; Littarru C; Guiglia R; Giuliani M Gerodontology; 2012 Jun; 29(2):e1207-14. PubMed ID: 22612839 [TBL] [Abstract][Full Text] [Related]
55. A phase II trial using thalidomide for Langerhans cell histiocytosis. McClain KL; Kozinetz CA Pediatr Blood Cancer; 2007 Jan; 48(1):44-9. PubMed ID: 16333818 [TBL] [Abstract][Full Text] [Related]
56. Unifocal Langerhans cell histiocytosis of the oral mucosa. Fistarol S; Itin P; Häusermann P; Oberholzer M; Raineri I; Lambrecht T; Lindenmüller IH J Dtsch Dermatol Ges; 2009 Jul; 7(7):620-2. PubMed ID: 19228294 [TBL] [Abstract][Full Text] [Related]
57. "Blueberry muffin" rash and large right thigh mass: a unique presentation of Langerhans cell histiocytosis. Lau EG; Stepenaskie S; Moran R; Quinn R; Matthew P; Smidt AC Dermatol Online J; 2013 Jun; 19(6):18568. PubMed ID: 24011317 [TBL] [Abstract][Full Text] [Related]
58. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Titgemeyer C; Grois N; Minkov M; Flucher-Wolfram B; Gatterer-Menz I; Gadner H Med Pediatr Oncol; 2001 Aug; 37(2):108-14. PubMed ID: 11496348 [TBL] [Abstract][Full Text] [Related]